• December 13, 2019

The Future of the World Microneedles and Needle-Free Injection Systems/Jet Injectors Market (2019-2030) - ResearchAndMarkets.com - Odessa American: Business

e-Edition Subscribe

The Future of the World Microneedles and Needle-Free Injection Systems/Jet Injectors Market (2019-2030) - ResearchAndMarkets.com

Print
Font Size:
Default font size
Larger font size

Posted: Wednesday, November 27, 2019 4:33 am

DUBLIN--(BUSINESS WIRE)--Nov 27, 2019--

The "Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030" report has been added to ResearchAndMarkets.com's offering.

The field of needleless drug delivery continues to witness significant advances, in terms of innovation in drug/therapy administration (such as dose tracking and real-time updates) and the development of compatible drug formulations. As a result, several stakeholders in the healthcare industry have developed interest in this upcoming field, and have launched product development/commercialization initiatives in the recent past.

This report features an extensive study of the current landscape and the likely future opportunities associated with the needle-free injection systems and microneedles market, over the next 10-12 years. Amongst other elements, the report includes:

  • A detailed review of the overall landscape of the needle-free injection systems market, featuring a comprehensive list of device developers and analysis based on a number of parameters, such as year of establishment, company size, geographical location, current development status of various products (under development and commercialized), details on intellectual property portfolio, route of administration (subcutaneous, intramuscular, intradermal and others), type of load (solid and liquid), usability (disposable and reusable), actuation mechanism (spring-based, gas-powered and others), capacity of the device (in terms of volume of drug delivered) and target disease areas.
  • An overview of the current market landscape of microneedle devices, featuring a comprehensive list of device developers and analysis based on a number of parameters, such as year of establishment, company size, geographical location, current development status of various products (under development and commercialized), details on intellectual property portfolio, type of microneedle device (hollow, solid and dissolving), route of administration (subcutaneous, transdermal, intradermal and others), microneedle length and target disease areas.
  • A detailed product competitiveness analysis of both needle-free injection systems and microneedle devices, taking into consideration the supplier power (based on the year of establishment of developer company) and key product specifications. For needle-free injection systems, specifications, such as therapeutic area, route of administration, maximum device volume, usability, size of intellectual property portfolio, and commercial availability, were considered. For microneedles, specifications, such as therapeutic area, route of administration, length of microneedle, and size of intellectual property portfolio, were considered.
  • A list of marketed drugs/therapies and pipeline candidates that are anticipated to be developed in combination with needle free injectors and microneedles in the near future; the analysis is based on a variety of relevant parameters, such as (in alphabetical order) current status of development, dose concentration, dosing frequency, route of administration, type of dose (standard/weight dependent), expected patent expiry (relevant only for marketed drugs) and information on product sales (relevant only for marketed drugs).
  • An informed business portfolio analysis based on an attractiveness and competitiveness (AC) framework, highlighting the current worth of different types of needle-free injection systems and microneedle devices.
  • Elaborate profiles of prominent product developers engaged in this domain. Each profile features a brief overview of the company, its financial information (if available), information on its product portfolio and recent developments.
  • A case study on the role of contract manufacturing organizations within the medical device industry. It includes a brief description of the various regulatory guidelines for medical devices and highlights the challenges associated with the manufacturing of such products. In addition, it features a list of contract manufacturers that claim to offer services for drug delivery devices and their geographical landscape.

One of the key objectives of the report was to estimate the existing market size and potential future growth opportunities for needle-free injection systems and microneedle devices. Based on various parameters, such as number of marketed/pipeline products, existing price of devices (for commercially available products only) and estimated annual adoption rate, we have provided an informed estimate on the likely evolution of the market over the period 2019-2030.

For needle-free injection systems, the report also features the likely distribution of the current and forecasted opportunity across [A] different types of actuation mechanisms (spring-based, gas powered and others), [B] routes of administration (subcutaneous, intramuscular and intradermal), [C] target disease indication (infectious diseases, diabetes, pain disorders and others), [D] product usability (disposable and re-usable) and [E] key geographical regions (North America, Europe, Asia and Rest of the World).

Similarly, the projected future opportunity for microneedle devices has been analyzed across [A] various types of microneedle devices (hollow, solid and dissolving), [B] target disease indication (infectious diseases, osteoarthritis, pain disorders, cancer, and others), [C] type of intervention (vaccines, therapeutic agent and others), and [D] key geographical regions (North America, Europe, Asia and Rest of the World).

In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth.

The opinions and insights presented in the report were influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following industry stakeholders:

  • Michael Schrader, CEO and Founder, Vaxess Technologies
  • Patrick Anquetil, CEO, Portal Instruments
  • Henry King, Market Intelligence and Business Development Manager, Innoture

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Key Topics Covered

1 PREFACE

1.1. Scope of the Report

1.2. Research Methodology

1.3. Chapter Outlines

2 EXECUTIVE SUMMARY

3 INTRODUCTION

3.1 Chapter Overview

3.2. Conventional Parenteral Drug Delivery

3.2.1. Needlestick Injuries

3.2.2. Incidence and Cost Burden Related to Needlestick Injuries

3.3. Minimally Invasive Drug Delivery

3.3.1. Key Drivers of Minimally Invasive Drug Delivery Systems

3.3.1.1. Rising Burden of Chronic Diseases

3.3.1.2. Healthcare Cost Savings

3.3.1.3. Need for Immediate Treatment in Emergency Situations

3.3.1.4. Growing Injectable Drugs Market

3.3.1.5. Need for Improving Medication Adherence

3.4. Needle-Free Injection Technology

3.5. Drug Delivery through Microneedle Devices

3.6. Needle-Free Injection Systems and Microneedle Devices: Unaddressed Challenges

3.7. Future of Needle-Free Injection Systems and Microneedle Devices

4 NEEDLE-FREE INJECTION SYSTEMS: MARKET OVERVIEW

4.1. Chapter Overview

4.2. Needle-Free Injection Systems: List of Developers

4.3. Needle-Free Injection Systems: List of Available / Under Development Devices

4.4. Needle-Free Injection Systems: Additional Information

4.5. Needle-Free Injection Systems: Recent Partnerships (2015-2019)

5 MICRONEEDLE DEVICES: MARKET OVERVIEW

5.1. Chapter Overview

5.2. Microneedle Devices: List of Developers

5.3. Microneedle Devices: List of Available / Under Development Devices

6 PRODUCT COMPETITIVENESS ANALYSIS

6.1. Chapter Overview

6.2. Methodology

6.3. Assumptions and Key Parameters

6.4. Product Competitiveness Analysis: Needle-Free Injection Systems

6.5. Product Competitiveness Analysis: Microneedle Devices

7 COMPANY PROFILES

7.1. Chapter Overview

7.2. Inovio Pharmaceuticals

7.3. Medical International Technology

7.4. D'Antonio Consultants International

7.5. Enesi Pharma

7.6. PharmaJet

7.7. Inolife Sciences

7.8. Valeritas

7.9. NanoPass Technologies

7.10. 3M

7.11. Micropoint Technologies

7.12. Nemaura Pharma

8 AC MATRIX

8.1. Chapter Overview

8.2. AC Matrix: An Overview

8.3. AC Matrix: Analytical Methodology

8.4. AC Matrix: Plotting the Information

8.5. AC Matrix: Analyzing the Data

8.6. Concluding Remarks

9 CASE STUDY: DRUG DELIVERY DEVICE CONTRACT MANUFACTURERS

9.1. Chapter Overview

9.2. Challenges Associated with Medical Device Manufacturing

9.3. Role of Contract Manufacturing Organizations in the Device Development Process

9.4. Regulatory Guidelines for Medical Devices

9.5. Drug Delivery Device: List of Contract Manufacturers

9.6. Geographical Distribution of Device Developers and Contract Service Providers

10 NEEDLE-FREE INJECTION SYSTEMS: LIKELY DRUG CANDIDATES

10.1. Chapter Overview

10.2. Marketed Drugs Candidates

10.3. Clinical Drug Candidates (Biologics)

10.4. Clinical Drug Candidates (Small Molecules)

11 MICRONEEDLE DEVICES: LIKELY DRUG CANDIDATES

11.1. Chapter Overview

11.2. Marketed Drugs Candidates

11. 2.3. Less Likely Candidates for Delivery via Microneedle Devices

11. 2.4. Unlikely Candidates for Delivery via Microneedle Devices

11.3. Clinical Drug Candidates (Biologics)

11. 3.2. Likely Candidates for Delivery via Microneedle Devices

11. 3.3. Less Likely Candidates for Delivery via Microneedle Devices

11. 3.4. Unlikely Candidates for Delivery via Microneedle Devices

11.4. Clinical Drug Candidates (Small Molecules)

12 MARKET SIZING AND OPPORTUNITY ANALYSIS

12.1. Chapter Overview

12.2. Forecast Methodology and Key Assumptions

12.3. Global Needle-Free Injection Systems Market, 2019-2030

12.4. Global Needle-Free Injection Systems Market: Distribution by Actuation Mechanism, 2019-2030

12.5. Global Needle-Free Injection Systems Market: Distribution by Route of Administration, 2019-2030

12.6. Global Needle-Free Injection Systems Market: Distribution by Target Disease Indication, 2019-2030

12.7. Global Needle-Free Injection Systems Market: Distribution by Product Usability, 2019-2030

12.8. Global Needle-Free Injection Systems Market: Distribution by Regions, 2019-2030

12.9. Global Microneedle Devices Market, 2019-2030

12.10. Global Microneedle Devices Market: Distribution by Type of Microneedle, 2019-2030

12.11. Global Microneedle Devices Market: Distribution by Target Disease Indication, 2019- 2030

12.12. Global Microneedle Devices Market: Distribution by Type of Intervention, 2019-2030

12.13. Global Microneedle Devices Market: Distribution by Regions, 2019-2030

13 INTERVIEW TRANSCRIPTS

13.1. Chapter Overview

13.2. Vaxess Technologies

13.3. Portal Instruments

13.3. Innoture

14 CONCLUDING REMARKS

15 APPENDIX 1: TABULATED DATA

16 APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Companies Mentioned

  • 3M
  • AbbVie
  • AbGenomics
  • Ablynx
  • ABO Pharmaceuticals
  • Acceleron Pharma
  • Actavis Pharma
  • Activa Brand Products
  • ADC Therapeutics
  • AdminMed
  • Adrenomed
  • Aduro Biotech
  • Advaxis
  • Aeglea BioTherapeutics
  • Affibody
  • Agenus
  • AgonOx
  • Aijex Pharma International
  • AIM ImmunoTech
  • Akesobio Australia
  • AKRA DERMOJET
  • Alder BioPharmaceuticals
  • Alector
  • Alexion Pharmaceuticals
  • Alkahest
  • Alkermes
  • Allakos
  • Allergan
  • Allozyne
  • Alnylam Pharmaceuticals
  • AlphaCore Pharma
  • Altor BioScience
  • Ambrx
  • amcure
  • American Medical Systems
  • AMETEK Engineered Medical Components
  • Amgen
  • Amicus Therapeutics
  • Amphivena Therapeutics
  • Amplyx Pharmaceuticals
  • Amsino
  • Anesiva
  • Angiochem
  • Antares Pharma
  • Antaros Medical
  • Apex Medical Technologies
  • Apogee Technology
  • Aprea Therapeutics
  • Aptevo Therapeutics
  • argenx
  • and many, many more...

For more information about this report visit https://www.researchandmarkets.com/r/64f1qs

View source version on businesswire.com:https://www.businesswire.com/news/home/20191127005290/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/27/2019 05:33 AM/DISC: 11/27/2019 05:33 AM

http://www.businesswire.com/news/home/20191127005290/en

© 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Odessa, TX

Current Conditions

Sunny
67°
Humidity: 30%
Winds: W at 17mph
Feels Like: 67°

Your Extended Forecast

Tomorrow

weather
High 73°/Low 41°
Sunny and windy. Highs in the low 70s and lows in the low 40s.

saturday

weather
High 75°/Low 49°
Sunny. Highs in the mid 70s and lows in the upper 40s.

sunday

weather
High 76°/Low 40°
Sunshine. Highs in the mid 70s and lows in the low 40s.
Online Features

Pet Central

pets

Having a pet is a lot of responsibility, and we’ll help by giving you lots of tips and tricks! More >>

Fitness

Fitness

Our fitness articles will help teach you how to work out with gym- and home-based exercises. More >>

Crosswords

Crosswords

Enjoy the crosswords challenge in our free daily puzzles, from the harder Sunday crossword to the quicker daily. More >>

Sudoku

Sudoku

Every Sudoku has a unique solution that can be reached logically. Enter numbers into the blank spaces so that each row, column and 3x3 box contains the numbers 1 to 9. More >>




  • ALL-ACCESS: Subscribe to our e-edition and premium website at myoaoa.com.
    You can read your daily newspaper without taking a walk to the driveway.
    Look back at yesterday's newspaper, or issues from months ago with our archive feature.
    Call circulation at 432-337-7314 to sign up today.